|
| 33111565 | H2O2-Responsive Antioxidant Nanoparticle Attenuates Whole Body Ischemia/Reperfusion-Induced Multi-Organ Damages. | J Cardiovasc Pharmacol Ther | 2021 |
| 34622671 | Bilirubin Nanoparticles Protect Against Cardiac Ischemia/Reperfusion Injury in Mice. | J Am Heart Assoc | 2021 |
| 34068392 | The Prominin-1-Derived Peptide Improves Cardiac Function Following Ischemia. | Int J Mol Sci | 2021 |
| 32534073 | Neuropeptide Y<sub>3-36</sub> incorporated into PVAX nanoparticle improves angiogenesis in a murine model of myocardial ischemia. | Eur J Pharmacol | 2020 |
| 31991042 | Targeting of intragraft reactive oxygen species by APP-103, a novel polymer product, mitigates ischemia/reperfusion injury and promotes the survival of renal transplants. | Am J Transplant | 2020 |
| 33348578 | Oxidative Stress and Antioxidant Treatments in Cardiovascular Diseases. | Antioxidants (Basel) | 2020 |
| 32244653 | Systemic Review of Biodegradable Nanomaterials in Nanomedicine. | Nanomaterials (Basel) | 2020 |
| 29228781 | Targeting Oxidative Stress Using Nanoparticles as a Theranostic Strategy for Cardiovascular Diseases. | Antioxid Redox Signal | 2019 |
| 31418596 | Guidelines for evaluating myocardial cell death. | Am J Physiol Heart Circ Physiol | 2019 |
| 30104619 | Highly conductive, stretchable and biocompatible Ag-Au core-sheath nanowire composite for wearable and implantable bioelectronics. | Nat Nanotechnol | 2018 |
| 28736316 | Early Actions of Anti-Vascular Endothelial Growth Factor/Vascular Endothelial Growth Factor Receptor Drugs on Angiogenic Blood Vessels. | Am J Pathol | 2017 |
| 28302707 | Neuropeptide Y<sub>3-36</sub> incorporated into PVAX nanoparticle improves functional blood flow in a murine model of hind limb ischemia. | J Appl Physiol (1985) | 2017 |
| 28481519 | Fibrin-Targeted and H<sub>2</sub>O<sub>2</sub>-Responsive Nanoparticles as a Theranostics for Thrombosed Vessels. | ACS Nano | 2017 |
| 28957668 | Aldosterone-Sensing Neurons in the NTS Exhibit State-Dependent Pacemaker Activity and Drive Sodium Appetite via Synergy with Angiotensin II Signaling. | Neuron | 2017 |
| 28814738 | Identification of Novel Non-secosteroidal Vitamin D Receptor Agonists with Potent Cardioprotective Effects and devoid of Hypercalcemia. | Sci Rep | 2017 |
| 26744078 | A role of stochastic phenotype switching in generating mosaic endothelial cell heterogeneity. | Nat Commun | 2016 |
| 27930351 | Hydrogen Peroxide-Responsive Nanoparticle Reduces Myocardial Ischemia/Reperfusion Injury. | J Am Heart Assoc | 2016 |
| 27694217 | Carboxy-terminal deletion of the HDL receptor reduces receptor levels in liver and steroidogenic tissues, induces hypercholesterolemia, and causes fatal heart disease. | Am J Physiol Heart Circ Physiol | 2016 |
| 27270170 | Soluble fms-like tyrosine kinase 1 promotes angiotensin II sensitivity in preeclampsia. | J Clin Invest | 2016 |
| 27521705 | H2O2-responsive antioxidant polymeric nanoparticles as therapeutic agents for peripheral arterial disease. | Int J Pharm | 2016 |
| 26990752 | Soluble analog of ApoER2 targeting beta2-glycoprotein I in immune complexes counteracts hypertension in lupus-prone mice with spontaneous antiphospholipid syndrome. | J Thromb Haemost | 2016 |
| 25478810 | A new Mdr2(-/-) mouse model of sclerosing cholangitis with rapid fibrosis progression, early-onset portal hypertension, and liver cancer. | Am J Pathol | 2015 |
| 26328770 | Reactive oxygen species-activated nanomaterials as theranostic agents. | Nanomedicine (Lond) | 2015 |
| 26563741 | Hydrogen peroxide-activatable antioxidant prodrug as a targeted therapeutic agent for ischemia-reperfusion injury. | Sci Rep | 2015 |
| 26503151 | Diagnostic and Therapeutic Nanoparticles in Cardiovascular Diseases. | Curr Pharm Des | 2015 |
| 25890763 | p-Hydroxybenzyl alcohol-containing biodegradable nanoparticle improves functional blood flow through angiogenesis in a mouse model of hindlimb ischemia. | Biomaterials | 2015 |
| 25989107 | Exaggerated hypertensive response to combretastatin A-4 phosphate in hypertensive rats: Effective pharmacological inhibition by diltiazem. | Vascul Pharmacol | 2015 |
| 25775254 | Endothelin A receptor antagonist, atrasentan, attenuates renal and cardiac dysfunction in Dahl salt-hypertensive rats in a blood pressure independent manner. | PLoS One | 2015 |
| 24335973 | Hydrogen sulfide attenuates sFlt1-induced hypertension and renal damage by upregulating vascular endothelial growth factor. | J Am Soc Nephrol | 2014 |
| 25268137 | Abnormal calcium handling and exaggerated cardiac dysfunction in mice with defective vitamin d signaling. | PLoS One | 2014 |
| 25336613 | RhoA signaling in cardiomyocytes protects against stress-induced heart failure but facilitates cardiac fibrosis. | Sci Signal | 2014 |
| 24767791 | Therapeutic use of H2O2-responsive anti-oxidant polymer nanoparticles for doxorubicin-induced cardiomyopathy. | Biomaterials | 2014 |
| 24874427 | FOXO1-mediated activation of Akt plays a critical role in vascular homeostasis. | Circ Res | 2014 |
| 23590189 | Inflammation-responsive antioxidant nanoparticles based on a polymeric prodrug of vanillin. | Biomacromolecules | 2013 |
| 24096013 | Hydrogen peroxide-responsive copolyoxalate nanoparticles for detection and therapy of ischemia-reperfusion injury. | J Control Release | 2013 |
| 23868607 | H2O2-responsive molecularly engineered polymer nanoparticles as ischemia/reperfusion-targeted nanotherapeutic agents. | Sci Rep | 2013 |
| 23429874 | Vitamin D signaling pathway plays an important role in the development of heart failure after myocardial infarction. | J Appl Physiol (1985) | 2013 |
| 21387140 | Mitochondria to nucleus translocation of AIF in mice lacking Hsp70 during ischemia/reperfusion. | Basic Res Cardiol | 2011 |
| 22123370 | Doxercalciferol, a pro-hormone of vitamin D, prevents the development of cardiac hypertrophy in rats. | J Card Fail | 2011 |
| 21631422 | Mechanisms and inhibitors of apoptosis in cardiovascular diseases. | Curr Pharm Des | 2011 |
| 21631418 | Novel pharmacological therapies for cardiac hypertrophy and heart failure. | Curr Pharm Des | 2011 |
| 21565836 | Preventing progression of cardiac hypertrophy and development of heart failure by paricalcitol therapy in rats. | Cardiovasc Res | 2011 |
| 19633014 | Role of AIF in cardiac apoptosis in hypertrophic cardiomyocytes from Dahl salt-sensitive rats. | Cardiovasc Res | 2010 |
| 20833960 | Delayed activation of caspase-independent apoptosis during heart failure in transgenic mice overexpressing caspase inhibitor CrmA. | Am J Physiol Heart Circ Physiol | 2010 |
| 20555426 | Exacerbation of acute viral myocarditis by tobacco smoke is associated with increased viral load and cardiac apoptosis. | Can J Physiol Pharmacol | 2010 |
| 20664736 | Apoptosis in cardiovascular diseases: mechanism and clinical implications. | Korean Circ J | 2010 |
| 20178044 | Vitamin D deficiency and cardiovascular disease: Is there a role for vitamin D therapy in heart failure? | Curr Opin Investig Drugs | 2010 |
| 19060119 | Exercise-induced expression of VEGF and salvation of myocardium in the early stage of myocardial infarction. | Am J Physiol Heart Circ Physiol | 2009 |
| 19737629 | Pharmacological inhibition of the hypertensive response to combretastatin A-4 phosphate in rats. | Vascul Pharmacol | 2009 |
| 19122165 | Phosphoinositide 3-kinase Akt signaling pathway interacts with protein kinase Cbeta2 in the regulation of physiologic developmental hypertrophy and heart function. | Am J Physiol Heart Circ Physiol | 2009 |